OmniAb (OABI) Enterprise Value (2021 - 2026)
OmniAb (OABI) reported Enterprise Value of -$43.0 million for Q1 2026, up 1.44% year-over-year from -$42.4 million in Q1 2025, and up 11.56% quarter-over-quarter from -$48.6 million in Q4 2025.
OmniAb (OABI) Enterprise Value (2021 - 2026) Analysis & Trends
OmniAb (OABI) has 6 years of Enterprise Value data on file, last reported at -$43.0 million in Q1 2026.
- Enterprise Value for Q1 2026 came in at -$43.0 million, up 1.44% year-over-year; the trailing twelve-month figure through Mar 2026 was -$43.0 million (up 1.44% YoY), and the FY2025 annual result was -$48.6 million, up 1.76% from the prior year.
- Enterprise Value improved to -$43.0 million in Q1 2026 per OABI's latest filing, from -$48.6 million in the prior quarter.
- Over five years, Enterprise Value peaked at -$19847.0 in Q3 2022 and troughed at -$113.6 million in Q1 2023.
- A 5-year average of -$56.5 million and a median of -$57.2 million in 2024 frame the typical range for Enterprise Value.
- The sharpest annual moves came in 2022 and 2023: Enterprise Value surged 94.52% in 2022, then tumbled 486764.51% in 2023.
- A 5-year view of Enterprise Value shows it stood at -$88.3 million in 2022, then increased by 1.45% to -$87.0 million in 2023, then surged by 43.15% to -$49.5 million in 2024, then gained by 1.76% to -$48.6 million in 2025, then advanced by 11.56% to -$43.0 million in 2026.
- Business Quant data shows OABI's Enterprise Value at -$43.0 million in Q1 2026, -$48.6 million in Q4 2025, and -$59.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -32.30 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -4.14 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -286.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -18.44 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.77 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -7.20 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -7.25 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -584.73 Mn |
| 10 | OmniAb | 294.96 Mn | 252.00 Mn | 14.41 Mn | -42.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -42.97 Mn |
| Dec 31, 2025 | -48.58 Mn |
| Sep 30, 2025 | -59.50 Mn |
| Jun 30, 2025 | -41.62 Mn |
| Mar 31, 2025 | -43.60 Mn |
| Dec 31, 2024 | -49.45 Mn |
| Sep 30, 2024 | -59.38 Mn |
| Jun 30, 2024 | -57.23 Mn |
| Mar 31, 2024 | -69.01 Mn |
| Dec 31, 2023 | -86.98 Mn |
| Sep 30, 2023 | -96.63 Mn |
| Jun 30, 2023 | -103.15 Mn |
| Mar 31, 2023 | -113.61 Mn |
| Dec 31, 2022 | -88.27 Mn |
| Sep 30, 2022 | -19,847.00 |
| Jun 30, 2022 | -159,194.00 |
| Mar 31, 2022 | -434,629.00 |
| Sep 30, 2021 | -362,203.00 |
| Jun 30, 2021 | -36,145.00 |